Medical News

RSS

2nd biannual fetal therapy reunion at Hollywood Presbyterian Medical Center

Over 200 infants and toddlers will converge at Hollywood Presbyterian Medical Center on Saturday, May 15 at a special event celebrating their lives and reuniting them and their parents with others who share similar experiences.

30 Apr 2010

Lotus Pharmaceuticals receives Chinese SFDA approval to commence Laevo-Bambuterol clinical trials

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).

30 Apr 2010

United Therapeutics reports strong revenue growth in first quarter 2010

United Therapeutics Corporation today announced its results of operations for the quarter ended March 31, 2010.

30 Apr 2010

Health law keeps 200,000 in state insurance plans instead of new high-risk pools

USA Today: About 200,000 people already enrolled in 35 state high-risk insurance pools "will not be allowed to enroll this summer in a new lower cost federal program for people like them because they already buy pricey state-run plans." In order to be eligible, "a person can't have had health coverage for six months.

30 Apr 2010

A major research initiative to optimize quality of life for cancer survivors

At the age of 12, she was diagnosed with spinal cord cancer, with a nasty tumor sitting at the very base of her spinal cord and getting entangled with spinal nerves.

30 Apr 2010

Mylan first-quarter total revenues increase 7% to $1.29 billion

Mylan Inc. today announced its financial results for the three months ended March 31, 2010.

30 Apr 2010

Call for an independent inquiry into Queensland Health payroll debacle

There has been a major payroll error leaving tens of thousands of healthcare staff short of cash or without pay in the past few weeks in Queensland after the introduction of a new computerized payroll system last month.

30 Apr 2010

Financial Times reports on challenges NGOs, development agencies face when partnering with businesses

The Financial Times reports on some of the challenges non-governmental organizations and development agencies face as they grow more accustomed to partnerships with businesses.

30 Apr 2010

FDA approves new treatment option for prostate cancer

Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration.

30 Apr 2010

$EnzymeRx reports positive results from first clinical trial of pegsitacase for refractory gout$

EnzymeRx reports positive results from first clinical trial of pegsitacase for refractory gout

EnzymeRx, LLC, a clinical-stage biotechnology company, announced top line results from its first clinical trial of pegsitacase (formerly called Uricase‑PEG 20). Pegsitacase is a pegylated uricase being developed by EnzymeRx for the treatment of refractory gout and for the management of hyperuricemia associated with tumor lysis syndrome.

30 Apr 2010

Women with family history of breast cancer face increase risk of ovarian cancer

Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.

30 Apr 2010

IPS examines how Uganda's anti-counterfeit bill could impact access to generic drugs

Inter Press Service examines Uganda's "controversial Counterfeit Goods Bill," which some say will limit the public's access to "life-saving generic medicines."

30 Apr 2010

Seniors often don't choose best quality Medicare Advantage plans, study finds

The Associated Press: "Millions of seniors signed up for popular Medicare Advantage insurance plans don't get the best quality, an independent study found. How the private plans score on a quality rating system set up by the government is about to have a direct impact on insurers' finances — not to mention seniors' benefits and premiums.

30 Apr 2010

Immunogen reports a net loss of $12.1 million in third quarter 2010

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended March 31, 2010 - the third quarter of the Company's 2010 fiscal year (3QFY10).

30 Apr 2010

Impax initiates challenge of patent listed by Shionogi Pharma concerning Fenoglide

Impax Laboratories, Inc. today confirms that it has initiated a challenge of a patent listed by Shionogi Pharma, Inc. in connection with its Fenoglide® (fenofibrate) tablets, 40 and 120 mg.

30 Apr 2010

Tel Aviv scientist uncovers a new way of detecting multiple sclerosis

Multiple sclerosis (MS) is an equal opportunity destroyer. It attacks the central nervous system and eventually renders most patients disabled. Among its high-profile victims are celebrated cellist Jacqueline du Pre, whose career was ended by MS, and Joan Didion, one of America's greatest writers - but they are far from alone.

30 Apr 2010

Study shows organic snackers underestimate calorie counts

Could organic labels lead you to overeat? These labels certainly appear to make people think their organic snack has a lot fewer calories than it really does.

30 Apr 2010

West Pharmaceutical Services reports 13.3% increase in first-quarter consolidated sales

West Pharmaceutical Services, Inc. today announced its results for the first quarter of 2010.

30 Apr 2010

Gonorrhea may soon become untreatable according to WHO

According to the World Health organization (WHO), gonorrhea may soon become untreatable and urgent measures need to be taken to prevent and treat the sexually transmitted infection. This is the result of improper use of first line antibiotics which has led to widespread anti microbial resistance to drugs. The cheaper antibiotics no longer have as much effect as they should and the higher antibiotics will soon lose efficacy as well.

30 Apr 2010

UC Irvine scientists receive CIRM grants for stem cell research

Two UC Irvine scientists will receive grants totaling more than $2.6 million to study the underlying biology of stem cells aimed at treating spinal cord injury, cancer and other disorders.

30 Apr 2010

Medical News

2nd biannual fetal therapy reunion at Hollywood Presbyterian Medical Center

Lotus Pharmaceuticals receives Chinese SFDA approval to commence Laevo-Bambuterol clinical trials

United Therapeutics reports strong revenue growth in first quarter 2010

Health law keeps 200,000 in state insurance plans instead of new high-risk pools

A major research initiative to optimize quality of life for cancer survivors

Mylan first-quarter total revenues increase 7% to $1.29 billion

Call for an independent inquiry into Queensland Health payroll debacle

Financial Times reports on challenges NGOs, development agencies face when partnering with businesses

FDA approves new treatment option for prostate cancer

EnzymeRx reports positive results from first clinical trial of pegsitacase for refractory gout

Women with family history of breast cancer face increase risk of ovarian cancer

IPS examines how Uganda's anti-counterfeit bill could impact access to generic drugs

Seniors often don't choose best quality Medicare Advantage plans, study finds

Immunogen reports a net loss of $12.1 million in third quarter 2010

Impax initiates challenge of patent listed by Shionogi Pharma concerning Fenoglide

Tel Aviv scientist uncovers a new way of detecting multiple sclerosis

Study shows organic snackers underestimate calorie counts

West Pharmaceutical Services reports 13.3% increase in first-quarter consolidated sales

Gonorrhea may soon become untreatable according to WHO

UC Irvine scientists receive CIRM grants for stem cell research

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News